265 related articles for article (PubMed ID: 28739581)
1. A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.
de Vries EM; Wang J; Williamson KD; Leeflang MM; Boonstra K; Weersma RK; Beuers U; Chapman RW; Geskus RB; Ponsioen CY
Gut; 2018 Oct; 67(10):1864-1869. PubMed ID: 28739581
[TBL] [Abstract][Full Text] [Related]
2. Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis.
Goet JC; Floreani A; Verhelst X; Cazzagon N; Perini L; Lammers WJ; de Vries AC; van der Meer AJ; van Buuren HR; Hansen BE
J Hepatol; 2019 Nov; 71(5):992-999. PubMed ID: 31278949
[TBL] [Abstract][Full Text] [Related]
3. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
[TBL] [Abstract][Full Text] [Related]
4. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
de Vries EM; de Krijger M; Färkkilä M; Arola J; Schirmacher P; Gotthardt D; Goeppert B; Trivedi PJ; Hirschfield GM; Ytting H; Vainer B; Buuren HR; Biermann K; Harms MH; Chazouilleres O; Wendum D; Kemgang AD; Chapman RW; Wang LM; Williamson KD; Gouw AS; Paradis V; Sempoux C; Beuers U; Hübscher SG; Verheij J; Ponsioen CY
Hepatology; 2017 Mar; 65(3):907-919. PubMed ID: 27880989
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.
Goode EC; Clark AB; Mells GF; Srivastava B; Spiess K; Gelson WTH; Trivedi PJ; Lynch KD; Castren E; Vesterhus MN; Karlsen TH; Ji SG; Anderson CA; Thorburn D; Hudson M; Heneghan MA; Aldersley MA; Bathgate A; Sandford RN; Alexander GJ; Chapman RW; Walmsley M; ; Hirschfield GM; Rushbrook SM
Hepatology; 2019 May; 69(5):2120-2135. PubMed ID: 30566748
[TBL] [Abstract][Full Text] [Related]
6. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
7. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
8. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
Deneau MR; El-Matary W; Valentino PL; Abdou R; Alqoaer K; Amin M; Amir AZ; Auth M; Bazerbachi F; Broderick A; Chan A; Cotter J; Doan S; El-Youssef M; Ferrari F; Furuya KN; Gottrand M; Gottrand F; Gupta N; Homan M; Kamath BM; Kim KM; Kolho KL; Konidari A; Koot B; Iorio R; Ledder O; Mack C; Martinez M; Miloh T; Mohan P; O'Cathain N; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Jensen MK
Hepatology; 2017 Aug; 66(2):518-527. PubMed ID: 28390159
[TBL] [Abstract][Full Text] [Related]
9. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan.
Tanaka A; Tazuma S; Nakazawa T; Isayama H; Tsuyuguchi T; Inui K; Takikawa H
J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):217-225. PubMed ID: 28103424
[TBL] [Abstract][Full Text] [Related]
10. Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis.
Lemoinne S; Cazzagon N; El Mouhadi S; Trivedi PJ; Dohan A; Kemgang A; Ben Belkacem K; Housset C; Chretien Y; Corpechot C; Hirschfield G; Floreani A; Motta R; Gallix B; Barkun A; Barkun J; Chazouillères O; Arrivé L
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2785-2792.e3. PubMed ID: 30880273
[TBL] [Abstract][Full Text] [Related]
11. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients.
Nordenvall C; Olén O; Nilsson PJ; von Seth E; Ekbom A; Bottai M; Myrelid P; Bergquist A
Aliment Pharmacol Ther; 2018 Jan; 47(2):238-245. PubMed ID: 29064110
[TBL] [Abstract][Full Text] [Related]
12. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.
Tischendorf JJ; Hecker H; Krüger M; Manns MP; Meier PN
Am J Gastroenterol; 2007 Jan; 102(1):107-14. PubMed ID: 17037993
[TBL] [Abstract][Full Text] [Related]
13. Validation of a cholangiographic prognostic model in primary sclerosing cholangitis.
Ponsioen CY; Reitsma JB; Boberg KM; Aabakken L; Rauws EA; Schrumpf E
Endoscopy; 2010 Sep; 42(9):742-7. PubMed ID: 20623444
[TBL] [Abstract][Full Text] [Related]
14. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
[TBL] [Abstract][Full Text] [Related]
15. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.
Okolicsanyi L; Fabris L; Viaggi S; Carulli N; Podda M; Ricci G
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):685-91. PubMed ID: 8853259
[TBL] [Abstract][Full Text] [Related]
16. Pretransplant prediction of prognosis after liver transplantation in primary sclerosing cholangitis using a Cox regression model.
Neuberger J; Gunson B; Komolmit P; Davies MH; Christensen E
Hepatology; 1999 May; 29(5):1375-9. PubMed ID: 10216118
[TBL] [Abstract][Full Text] [Related]
17. Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value.
de Vries EM; Wang J; Leeflang MM; Boonstra K; Weersma RK; Beuers UH; Geskus RB; Ponsioen CY
Liver Int; 2016 Dec; 36(12):1867-1875. PubMed ID: 26945698
[TBL] [Abstract][Full Text] [Related]
18. Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis.
de Vries EM; Verheij J; Hubscher SG; Leeflang MM; Boonstra K; Beuers U; Ponsioen CY
J Hepatol; 2015 Nov; 63(5):1212-9. PubMed ID: 26095184
[TBL] [Abstract][Full Text] [Related]
19. Serum miRNA-122 is an independent biomarker of survival in patients with primary sclerosing cholangitis.
Friedrich K; Baumann C; Wannhoff A; Rupp C; Mehrabi A; Weiss KH; Gotthardt DN
J Gastrointestin Liver Dis; 2018 Jun; 27(2):145-150. PubMed ID: 29922759
[TBL] [Abstract][Full Text] [Related]
20. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
Bossen L; Vesterhus M; Hov JR; Färkkilä M; Rosenberg WM; Møller HJ; Boberg KM; Karlsen TH; Grønbæk H
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00315. PubMed ID: 33646203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]